Skip to main content
. 2014 Nov 27;7:2175–2181. doi: 10.2147/OTT.S70654

Table 3.

Summary of grade 3/4 adverse events

Adverse event Patients, n (%)
Grade 3/4 adverse events 35 (44.9)
 Neutropenia 17 (21.8)
 Asthenia 7 (8.9)
 Hypertension 6 (7.6)
 Febrile neutropenia 4 (5.1)
 Proteinuria 3 (5.1)
 Mucositis 3 (3.8)
 Thrombocytopenia 2 (2.5)
 Peripheral neuropathy 2 (2.5)
 Bleeding 2 (2.5)
 Thromboembolic disease 1 (1.2)
 Brain stroke 1 (1.2)